VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 3 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2018. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2018 | $243,000 | +10.0% | 10,451 | -24.6% | 0.01% | +20.0% |
Q1 2018 | $221,000 | -46.0% | 13,863 | -29.5% | 0.01% | -28.6% |
Q4 2017 | $409,000 | +39.6% | 19,663 | -3.8% | 0.01% | +40.0% |
Q3 2017 | $293,000 | -17.2% | 20,432 | -0.3% | 0.01% | -16.7% |
Q2 2017 | $354,000 | +49.4% | 20,486 | -4.7% | 0.01% | +50.0% |
Q1 2017 | $237,000 | -22.8% | 21,502 | +1.5% | 0.01% | -33.3% |
Q4 2016 | $307,000 | -45.8% | 21,174 | -8.1% | 0.01% | -40.0% |
Q3 2016 | $566,000 | +32.9% | 23,045 | +9.0% | 0.02% | +25.0% |
Q2 2016 | $426,000 | -17.0% | 21,135 | +8.4% | 0.02% | -20.0% |
Q1 2016 | $513,000 | -72.1% | 19,496 | +7.8% | 0.02% | -71.4% |
Q4 2015 | $1,839,000 | -41.7% | 18,091 | +2.4% | 0.07% | -46.2% |
Q3 2015 | $3,153,000 | -12.2% | 17,674 | +9.3% | 0.13% | -7.8% |
Q2 2015 | $3,591,000 | +5.8% | 16,163 | -5.4% | 0.14% | +20.5% |
Q1 2015 | $3,394,000 | +38.6% | 17,089 | -0.1% | 0.12% | +39.3% |
Q4 2014 | $2,448,000 | +8.3% | 17,109 | -0.7% | 0.08% | +23.5% |
Q3 2014 | $2,261,000 | -1.4% | 17,234 | -5.2% | 0.07% | -2.9% |
Q2 2014 | $2,293,000 | -7.1% | 18,180 | -2.9% | 0.07% | -9.1% |
Q1 2014 | $2,469,000 | +0.7% | 18,729 | -10.3% | 0.08% | +13.2% |
Q4 2013 | $2,452,000 | -15.0% | 20,883 | -24.5% | 0.07% | -5.6% |
Q3 2013 | $2,885,000 | +10.4% | 27,654 | -8.9% | 0.07% | +18.0% |
Q2 2013 | $2,614,000 | – | 30,364 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |